Multiple Securities Lawsuits Filed Against Coty Over Alleged Concealment of Business Weakness

Overview

• Plaintiff firms including Pomerantz, Hagens Berman and others have filed competing class actions in the U.S. District Court for the Southern District of New York alleging Coty misled investors about its Consumer Beauty and Prestige fragrance performance.
• The complaints cover an expanded class period running from May 7, 2025 through February 4, 2026 and accuse Coty and certain former officers of concealing worsening Consumer Beauty sales, compressed margins from rising marketing spending, and slowing fragrance growth.
• Coty disclosed disappointing second‑quarter fiscal 2026 results after the market closed on February 4–5, 2026, withdrew its full‑year EBITDA and free‑cash‑flow guidance, and its share price fell roughly 22% by February 6, 2026.
• May 22, 2026 is the deadline for investors to seek appointment as Lead Plaintiff, and law firms are soliciting investors, witnesses and whistleblowers to support claims and to press for lead‑plaintiff status.
• If a lead plaintiff is appointed the case will move through motions to dismiss, discovery and possible settlement or trial, with recovery for investors remaining uncertain and dependent on proof of the alleged securities law violations.